Maryse Guay
Overview
Explore the profile of Maryse Guay including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
52
Citations
1417
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Bastien M, Guay M, Cambron-Goulet E, Lajoie E, Berbiche D, Kadaoui N
J Occup Environ Med
. 2023 Sep;
65(12):e776-e784.
PMID: 37757742
Objectives: The aims of the studies are to describe COVID-19 outbreaks in the workplaces of the Monteregie Region, Quebec, Canada, and to evaluate potential risk factors for identifying at least...
2.
Dube E, Trottier M, Vivion M, Ouakki M, Brousseau N, Guay M, et al.
BMC Pregnancy Childbirth
. 2022 Jun;
22(1):477.
PMID: 35698053
Background: In Canada, vaccination against pertussis (Tdap) during pregnancy has been recommended since 2018, with suboptimal uptake. We aimed to assess the determinants of intention and uptake of Tdap vaccine...
3.
Li Y, Brousseau N, Guay M, Dube E, Laghdir Z, Boucoiran I, et al.
CMAJ Open
. 2022 Feb;
10(1):E56-E63.
PMID: 35105682
Background: Vaccination of pregnant people with a vaccine containing acellular pertussis (tetanus-diphtheria-acellular pertussis [Tdap]) has been recommended in Canada since 2018, and the evaluation of delivery models for efficient maternal...
4.
Beauregard M, Brousseau N, Ouakki M, Kiely M, Sauvageau C, Clement P, et al.
Hum Vaccin Immunother
. 2020 May;
16(12):3170-3176.
PMID: 32429743
Multicomponent interventions are effective in improving vaccine coverage. However, few studies have assessed their effect on timely vaccination. The aim of this study was to compare the proportion of children...
5.
Dube E, Gagnon D, Kaminsky K, Green C, Ouakki M, Bettinger J, et al.
Hum Vaccin Immunother
. 2020 Apr;
16(11):2789-2799.
PMID: 32271655
A number of countries have implemented vaccination in pregnancy as a strategy to reduce the burden of influenza and pertussis. The aim of this study was to assess the involvement...
6.
Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, et al.
Vaccine
. 2019 Nov;
38(5):1202-1210.
PMID: 31759736
Background: Monitoring vaccination coverage is an essential component of vaccination program evaluation. In Québec (Canada), children vaccination coverage surveys are conducted every two years since 2006. The objectives of this...
7.
Guay M, Gosselin V, Petit G, Baron G, Gagneur A
Hum Vaccin Immunother
. 2019 May;
15(11):2527-2533.
PMID: 31050594
: Vaccine hesitancy is a global phenomenon that needs to be measured and addressed. This study aimed to identify the determinants of vaccine hesitancy among a large regional population.: A...
8.
Dube E, Gagnon D, Clement P, Bettinger J, Comeau J, Deeks S, et al.
Hum Vaccin Immunother
. 2019 Jan;
15(7-8):1650-1655.
PMID: 30633622
Primary prevention of human papillomavirus (HPV) through vaccination is a high priority in Canada's cancer prevention efforts. All Canadian provinces and territories have introduced publicly funded, school-based vaccination programs against...
9.
Kiely M, Boulianne N, Talbot D, Ouakki M, Guay M, Landry M, et al.
BMC Public Health
. 2018 Dec;
18(1):1364.
PMID: 30537969
Background: Timeliness in the administration of recommended vaccines is often evaluated using vaccine delays and provides more information regarding the susceptibility of children to vaccine-preventable diseases compared with vaccine coverage...
10.
Pare-Plante A, Boivin A, Berbiche D, Breton M, Guay M
BMC Fam Pract
. 2018 Dec;
19(1):188.
PMID: 30509205
Background: First-contact accessibility remains an important problem in Canada, with this indicator staying the worst of all Organization for Economic Co-operation and Development countries. In the province of Quebec, a...